AARTIPHARM.NS
AARTIPHARM.NS
INE0LRU01027
AARTI PHARMALABS LIMITED
Loading chart...

Company Profile

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, ophthalmologic, antidepressant medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates, such as xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. It serves pharmaceutical, nutraceutical, and beverage industries. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Related stocks

PGHL.BO
PGHL.BO • India
PROCTER & GAMBLE HEALTH LIMITE
5,215.55 INR
894.55M USD 1Y -17.2%
STAR.NS
STAR.NS • India
STRIDES PHARMA SCI LTD
1,085.3 INR
1.03B USD 1Y +37.4%
FDC.BO
FDC.BO • India
FDC LTD.
330.1 INR
555.32M USD 1Y -27.9%
ASTRAZEN.BO
ASTRAZEN.BO • India
ASTRAZENECA PHARMA INDIA LTD.
5,831.85 INR
1.51B USD 1Y -38.5%
IOLCP.BO
IOLCP.BO • India
IOL CHEMICALS & PHARMACEUTICAL
200.85 INR
609.17M USD 1Y +100.2%
NATCOPHARM.NS
NATCOPHARM.NS • India
NATCO PHARMA LTD.
789.4 INR
1.5B USD 1Y -1.7%
APLLTD.NS
APLLTD.NS • India
ALEMBIC PHARMA LTD
800.95 INR
1.63B USD 1Y -14%
AKUMS.NS
AKUMS.NS • India
AKUMS DRUGS AND PHARMA L
751.85 INR
1.19B USD 1Y +78.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
45.7% p.a.
Max Drawdown (5Y)
-38.6%
Sharpe Ratio (5Y)
0.70
Beta Factor
0.26
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (45.7% p.a.).
ende